DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Udenafil
Udenafil
Phosphodiesterase-5 Inhibitors and the Heart: Heart: First Published As 10.1136/Heartjnl-2017-312865 on 8 March 2018
Phosphodiesterase (PDE)
(Medical and Mechanical) Treatment of Erectile Dysfunction
Can PDE Inhibition Improve Cognition? : Translational Insights
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set
Pharmaceutical Appendix to the Tariff Schedule 2
Phosphodiesterase Type 5 Inhibitors - a Priority Direction for the Treatment of Erectile Dysfunction of Various Origins
Comparative Efficacy and Safety of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction in Diabetic Men: a Bayesian Netw
Phosphodiesterase 5 Inhibitors for the Treatment of Erectile Dysfunction: a Trade-Off Network Meta-Analysis
Udenafil, a Phosphodiesterase 5 Inhibitor, Reduces Body Weight in High-Fat-Fed Mice
Efficacy and Safety of Phosphodieterase-5
Effects of Repeated Dosing with Udenafil (Zydena) on Cognition, Somatization and Erection in Patients with Erectile Dysfunction: a Pilot Study
Safety, Tolerability and Pharmacokinetics of Udenafil, A
AVANAFIL: the SECOND-GENERATION TREATMENT of ERECTILE DYSFUNCTION *Giovanni Corona,1 Mario Maggi,2 Emmanuele A
New Treatments for Erectile Dysfunction
The Effect of Mirodenafil on the Penile Erection and Corpus Cavernosum in the Rat Model of Cavernosal Nerve Injury
(12) United States Patent (10) Patent No.: US 8,916,564 B2 Pettersson Et Al
Top View
(12) United States Patent (10) Patent No.: US 7.964,607 B2 Verhoest Et Al
PDE5 Inhibitors (Tadalafil, Sildenafil, Vardenafil)
Mirodenafil for the Treatment of Erectile Dysfunction: a Systematic Review of the Literature
Pharmaabkommen A1 E
ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
Application Number
Customs Tariff - Schedule Xxi - 1
Phosphodiesterase Inhibitors Say NO to Alzheimer's Disease
The Renoprotective Effects of Mannitol and Udenafil in Renal Ischemia-Reperfusion Injury Model
Malaysian Statistics on Medicines 2015-2016
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
The Use of Vasoactive Drugs in the Treatment of Male Erectile Dysfunction: Current Concepts
The Treatment of Erectile Dysfunction in Patients with Neurogenic Disease
Malaysian Statistics on Medicines 2011-2014
2020 Medicines in Development for Children
Chromatographic Separation and Identification of Sildenafil and Yohimbine Analogues Illegally Added in Herbal Supplements
Cgmp Signaling, Phosphodiesterases and Major Depressive Disorder
Udenafil for the Treatment of Erectile Dysfunction
[Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
RPCN Content
Results of a Phase I/II Multi-Center Investigation of Udenafil in Adolescents After Fontan Palliation
Drug Repurposing Compound Library (96-Well)
Erectile Dysfunction (1 of 11)
ISPOR Baltimore
Visual Side Effects Linked to Sildenafil Consumption: an Update
Therapeutic Effects of Udenafil on Pressure-Overload Cardiac
EAU Guidelines on Sexual and Reproductive Health 2020